# Stage 1 — Evidence Consolidation Log

**Date:** 2026-05-25
**Pipeline mode:** academic-pipeline (ars-full) — Stage 1 (deep-research / evidence gathering) → closure → Stage 2 (academic-paper planning) handoff
**Operator:** Claude Code (Opus 4.7)

---

## 1. Inputs reviewed

| Source | Content | Action |
|---|---|---|
| `CLAUDE.md` | Project identity, manuscript blueprint | Read |
| `SESSION_STATE.md` | Previous session state ("Waiting for user_survey") | Read |
| `prompt.md` (lines 1–400) | Full manuscript blueprint sections 1–4 | Read |
| `info/user_download/` | 47 curated PDFs + need.md | Inventoried via claude_survey |
| `info/claude_survey/00_summary.md` | Coverage status overview | Read |
| `info/claude_survey/01_already_downloaded.md` | 47-PDF annotated inventory | Read |
| `info/claude_survey/02_recommended_new_papers.md` | 23 new-paper recommendations | Read |
| `info/codex_survey/01_usable_for_study_broad/` | 461 PDFs | Title-level screen (no full-text reads) |
| `info/codex_survey/03_manual_screen_title_abstract/` | 287 PDFs | Title-level screen (no full-text reads) |

**Note:** The user previously planned a `user_survey/` folder; instead they delivered `codex_survey/` (≈748 PDFs from a parallel Claude-driven search). Survey logic therefore replaces `user_survey/` with `codex_survey/` in this consolidation.

---

## 2. codex_survey audit findings

**Screening method:** filename keyword filters (cisplatin, OSCC/HNSCC/head-and-neck/oral, circadian/chronotherapy/clock/melatonin, nephro/oto/mucositis/neuro-toxicity, XPA/NER/OCT2/CTR1, RTOG/EORTC/TAX/MACH-NC, wearable/actigraphy). No full-text PDF reads at this stage — content verification deferred to Stage 4 (integrity check).

**Buckets identified:**
- 25 unique, high-value supplementary papers absorbed into `reference/reference.md`
- ≈20 antiemetic phase-II trials (mostly off-topic for chronotherapy thesis, not promoted)
- ≈40 herbal / natural-compound cisplatin protectant papers (mostly low-quality, not promoted)
- Numerous chronobiology / sleep / actigraphy adjacent papers (not all promoted)
- **Critical absence:** Cooper/Bernier/Adelstein/Forastiere/Posner/Vermorken/Pignon Section-3 landmark trials remain unobtained

**Decision:** Promote only papers that (a) close a real evidence gap in `prompt.md` Section X, (b) come from a reputable specialist journal, and (c) are not already substituted by a `user_download/` paper of equal or greater authority. Net: 25 added; ~720 left in archive.

---

## 3. Outputs created this session

| File | Purpose |
|---|---|
| `reference/reference.md` | Consolidated evidence inventory (sections, sources, gaps, conceptual limitations) |
| `log/stage1_consolidation_2026-05-25.md` | This log |
| `SESSION_STATE.md` (updated) | Phase advanced from "Pre-writing — WAITING" to "Stage 2 — Planning" |
| `reference/`, `log/`, `full_paper/`, `figure/` directories | Created (previously absent) |

---

## 4. Persistent gaps for Stage 2 to flag

1. **Section 3 landmark trials (Tier 1, MUST):** Cooper 2004, Bernier 2004, Adelstein 2003, Forastiere 2003, Posner 2007, Vermorken 2007, Pignon 2009. Stage 2 planning should confirm with user whether to (a) pause for downloads or (b) draft §3 with placeholder citations to be filled before Stage 4 integrity check.
2. **Section 2 chemistry (Tier 2, HIGH):** Jamieson & Lippard 1999 Chem Rev.
3. **Section 4.2 prevention (Tier 2, NICE):** Brock 2018 NEJM SIOPEL 6.
4. **Section 4.4 modern antiemetic (Tier 2, NICE):** Herrstedt 2023 ESMO Open (partially substituted by Aapro 2016 NEPA from codex_survey).

---

## 5. Stage transition

- **Stage 1 status:** ✅ CLOSED
- **Stage 2 status:** ⏵ ENTERING (academic-paper `plan` mode — Socratic chapter-by-chapter outline)
- **Next operator action:** load `ars-plan` skill, walk §1→§8 through plan dialogue with user, anchoring each chapter on the per-section reference clusters in `reference/reference.md`.
